Aardvark Therapeutics, Inc.

AARD

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001774857

SEC filings (opens in a new tab)

In the last 90 days, Aardvark Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 71 institutions reported holding it in 13F filings for Q2 2026, worth $54.3M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Aardvark Therapeutics, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026 All holders in Q4 2025

13F holders of AARD: Q4 2025 compared with Q1 2026
Measure	Q4 2025	Of which not filed for Q1 2026	Q1 2026	Change
Holders	66	1	79	+14
Shares	10.7M	717.4K	10.2M	+169.3K (+1.7%)
Value	$141.0M	$9.42M	$38.5M	−$93.1M (−70.8%)

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Aardvark Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to AARD in Q1 2026
Institution	Shares	Value	% of portfolio
Vanguard Capital Management LLC	554,101	$2.09M	0.00%
Polygon Management Ltd.	316,621	$1.19M	0.23%
Adage Capital Partners GP, L.L.C.	300,000	$1.13M	0.00%
AQR Capital Management LLC	134,495	$507.0K	0.00%
Vanguard Fiduciary Trust Co	83,210	$313.7K	0.00%
Vanguard Portfolio Management LLC	75,149	$283.3K	0.00%
Woodline Partners LP	72,429	$273.1K	0.00%
Renaissance Technologies LLC	70,792	$266.9K	0.00%
Cresset Asset Management, LLC	43,259	$163.1K	0.00%
Prelude Capital Management, LLC	30,637	$115.5K	0.01%
Ieq Capital, LLC	16,485	$62.1K	0.00%
Raymond James Financial Inc	10,890	$41.1K	0.00%
Vanguard Global Advisers, LLC	5,893	$22.2K	0.00%
Simplex Trading, LLC	4,243	$16.0K	0.00%
Steward Partners Investment Advisory, LLC	4,150	$15.6K	0.00%
Federated Hermes, Inc.	1,083	$4.08K	0.00%
Essential Partners LLC	1,068	$4.03K	0.00%
Hilton Head Capital Partners, LLC	434	$1.64K	0.00%
MAI Capital Management	276	$1.04K	0.00%
Allworth Financial LP	207	$781	0.00%
Rothschild Investment LLC	77	$290	0.00%
True Wealth Design, LLC	49	$185	0.00%
Wealth Preservation Advisors, LLC	31	$117	0.00%
Farther Finance Advisors, LLC	28	$115	0.00%
The PNC Financial Services Group, Inc.	28	$106	0.00%
IFP Advisors, Inc	21	$79	0.00%
Harbour Investments, Inc.	20	$78	0.00%
Transamerica Financial Advisors, Inc.	14	$52	0.00%
Advisory Services Network, LLC	9	$34	0.00%
SRS Capital Advisors, Inc.	24	$23	0.00%
Sunbelt Securities, Inc.	4	$15	0.00%
SJS Investment Consulting Inc.	2	$8	0.00%

Sold out (18)

Institutions that held Aardvark Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of AARD in Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
SymBiosis Capital Partners, LLC	476,595	$6.26M
Superstring Capital Management LP	69,496	$912.1K
Schonfeld Strategic Advisors LLC	50,131	$658.0K
Propel Bio Management, LLC	46,408	$609.1K
Point72 Asset Management, L.P.	36,922	$484.6K
Jump Financial, LLC	34,575	$453.8K
HRT Financial LP	31,066	$407.0K
Two Sigma Advisers, LP	26,200	$343.9K
Diametric Capital, LP	19,309	$253.4K
Trexquant Investment LP	16,844	$221.1K
Los Angeles Capital Management LLC	20,837	$218.0K
Walleye Capital LLC	16,048	$210.6K
Diadema Partners LP	15,882	$208.5K
Balyasny Asset Management LLC	13,817	$181.3K
MetLife Investment Management	7,750	$101.7K
Persistent Asset Partners Ltd	4,231	$55.5K
Larson Financial Group LLC	506	$6.64K
Amalgamated Bank	400	$5.00K

Not filed for Q1 2026 yet (1)

Institutions that held Aardvark Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AARD in Q4 2025 that haven't filed for Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Vanguard Group Inc	717,430	$9.42M